Mutual of America Capital Management’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
VPM
VCM
AIM
Mutual of America Capital Management's VCYT Position: Q1 2026 in Review
Mutual of America Capital Management increased its Veracyte (VCYT) stake by 0.12% in Q1 2026, buying an estimated $407 and bringing the position to 9,046 shares worth $291K. The position accounts for ﹤0.01% of the portfolio, ranked #1217.
Mutual of America Capital Management first reported a position in VCYT in Q3 2025 and has held it in 3 quarters since. The position peaked at $380K in Q4 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.
- Mutual of America Capital Management held 9,046 shares of Veracyte worth $291K as of Q1 2026.
- Mutual of America Capital Management bought 11 Veracyte shares in Q1 2026, an estimated $407.
- Veracyte made up ﹤0.01% of Mutual of America Capital Management's portfolio in Q1 2026, its #1217 holding.
- Mutual of America Capital Management first reported a position in Veracyte in Q3 2025 and has held it in 3 quarters since.
- Mutual of America Capital Management's Veracyte position peaked at $380K in Q4 2025.
- 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.
Based on Mutual of America Capital Management's 13F filing for Q1 2026, filed 7 May 2026.